1-3 of 3
D Stafford
Close
Sort by
Journal Articles

Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Armando Morin, M.A., Ashley N. Morphey, M.S.N., Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Swami P. Iyer, MD, Lei Feng, MS, Behrang Amini, MD PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Ralph J. Johnson, PhD, Brandon N. Crumpton, Mildred D. Stafford, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139934
Published: 2020
Journal Articles

Carrier testing in hemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism

KJ Smith, AR Thompson, BA McMullen, D Frazier, SW Lin, D Stafford, W Kisiel, SN Thibodeau, SH Chen, LF Smith
Journal: Blood
Blood (1987) 70 (4): 1006–1013.
https://doi.org/10.1182/blood.V70.4.1006.1006
Published: 1987
Journal Articles

Antigenic determinant in human coagulation factor IX: immunological screening and DNA sequence analysis of recombinant phage map a monoclonal antibody to residues 111 through 132 of the zymogen

R McGraw, D Frazier, M de Serres, H Reisner, D Stafford
Journal: Blood
Blood (1986) 67 (5): 1344–1348.
https://doi.org/10.1182/blood.V67.5.1344.1344
Published: 1986